Lenus Pharma

What Lenus Pharma does

Lenus Pharma GesmbH is a privately held Austrian pharmaceutical company founded in Vienna in 2006 by Brigitte Annerl, MSc. It develops, manufactures, and distributes evidence-based dietary supplements and reproductive medicines across three therapeutic verticals: male and female fertility (PROFERTIL, PROFERTIL female, PROFERTIL inositol for PCOS), menopause and skin aging (MENOPEARL, with patented MF11RCE red clover isoflavones), and ophthalmology (four PROMACULA AREDS2-compliant variants for age-related macular degeneration). The company's product portfolio is anchored by patented formulations — including the PROFERTIL male formulation patented in the EU, USA, and Eurasia — supported by 19 clinical studies, with PROFERTIL inositol included in ESHRE/ASRM PCOS guidelines.

The company operates GMP-certified production in Austria and Germany and reinvests 15% of annual turnover into clinical research. Products are sold through a network of exclusive distribution partners across more than 70 countries, targeting physicians (gynecologists, urologists, ophthalmologists) who recommend the supplements to patients; the company claims more than 1 million patients served cumulatively, including 1 million yearly PROFERTIL therapies, 800,000 couples served via PROFERTIL female, and over 1.55 million cumulative PROMACULA users. Named channel partners include Abbott, Bharat Serum and Vaccines, Oktal Pharma, Laboratorios Rubió, Magnapharm, and several regional distributors in the Middle East and Asia.

The company is founder-controlled, with no disclosed parent company, institutional investors, or funding rounds since founding. It operates without app-based or API products and without disclosed AI/ML capabilities, relying instead on traditional pharmaceutical R&D and clinical evidence generation. Marketing is conducted through physician-targeted newsletters, medical content, and LinkedIn, with sales executed exclusively via distributor channels rather than direct-to-consumer.

Name

Lenus Pharma

Legal name

Lenus Pharma GesmbH

Website

https://lenuspharma.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Lenus Pharma is an Austrian pharmaceutical company that develops and distributes evidence-based dietary supplements for fertility (PROFERTIL line), menopause (MENOPEARL), and AMD (PROMACULA), sold via exclusive distributors in 70+ countries to physicians and patients worldwide.

Ownership category

akta.pro rank

Product category

Reproductive Health Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Fertility supplements
• Reproductive medicine
• Dietary supplements
• Pharmaceutical manufacturing
• Ophthalmology supplements

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical/Healthcare Product Sales: Lenus Pharma generates revenue through the sale of evidence-based healthcare products including dietary supplements for fertility (PROFERTIL, PROFERTIL female, PROFERTIL inositol), menopause (MENOPEARL), and ophthalmology (PROMACULA product line). Products are sold through a global network of distribution partners in 70+ countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Lenus Pharma manufactures and distributes evidence-based dietary supplements and clinical healthcare products across three therapeutic areas: male and female fertility (PROFERTIL line), menopause symptom relief (MENOPEARL), and age-related macular degeneration (PROMACULA line). Products are GMP-produced in Austria/Germany and sold through exclusive distribution partners in 70+ countries, reaching patients via physician recommendations.

Product overview

Lenus Pharma is an Austrian pharmaceutical company specializing in evidence-based healthcare products across urology, gynecology, and ophthalmology. The company operates GMP-certified production facilities in Austria and Germany and serves patients in over 70 countries. The product portfolio consists of two main therapeutic areas: (1) Fertility products including PROFERTIL® (male fertility supplement, patented formulation with 9 clinical studies), PROFERTIL® female (female fertility supplement with 4 clinical studies), and PROFERTIL® inositol (PCOS treatment with Myo-inositol); (2) Ophthalmological products including MENOPEARL® (menopause relief with red clover isoflavones) and four PROMACULA® variants (PROMACULA® areds2, lutein, max, and omega) all based on the AREDS2 formula for age-related macular degeneration treatment. The company invests 15% of annual turnover in clinical research and has 19 clinical studies supporting its formulations.

Differentiator

Problem solved

Functional benefit

Products and services

• PROFERTIL® Clinically tested dietary supplement to enhance male fertility. Unique patented formulation confirmed in 9 clinical studies to improve all sperm parameters (sperm count, motility, normal morphology) and reduce DNA strand breaks in sperm, increasing chances of successful conception.
• PROFERTIL® female The only study-proven fertility supplement worldwide for increasing female fertility. Clinically tested composition (4 clinical studies) protects ovaries from oxidative stress and improves conditions for successful fertilization including endometrial thickness, regular cycle, and regulated AMH levels.
• PROFERTIL® inositol Dietary supplement for the treatment of women with PCOS. The formulation with Myo-inositol supports hormonal balance during PCOS and improves insulin sensitivity, and is included as a treatment option in ESHRE/ASRM PCOS guidelines. Contains Quatrefolic (immediately bioavailable folate) and vitamin B6.
• MENOPEARL® Clinically proven product for the relief of menopausal symptoms and improvement of skin appearance. Contains MF11RCE® red clover isoflavones, proven in 6 clinical studies to reduce hot flashes by 74%, night sweats by 72%, and improve depressive moods and anxiety.
• PROMACULA® areds2 100% AREDS2-compliant formula for AMD treatment (categories 3 & 4) with 25 mg zinc, particularly well tolerated by patients with sensitive stomachs, gastrointestinal complaints, or low body weight.
• PROMACULA® lutein 100% AREDS2-compliant formula for the treatment of AMD (age-related macular degeneration) in categories 3 & 4, based on the repeatedly confirmed AREDS2 formulation.
• PROMACULA® max 100% AREDS2-compliant formula for AMD treatment (categories 3 & 4) with valuable antioxidants and folic acid. Also suitable for patients with diabetic retinopathy and those with swallowing difficulties, as the capsule can be opened for oral administration.
• PROMACULA® omega 100% AREDS2-compliant formula for AMD treatment (categories 3 & 4) with the added benefit of premium omega-3 fatty acids. Supports tear fluid production, making it suitable for patients with AMD combined with dry eyes (keratoconjunctivitis sicca).

Quantifiable outcome

• Hot flashes reduced by 74%, night sweats by 72% with MENOPEARL
• +4 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core.

• Bharat Serum and VaccinescoreChannel Partner/ Reseller/ DistributorDistribution partner for Lenus Pharma products in various international markets. Listed as a key partner on the Lenus Pharma partner page.
• AbbottcoreChannel Partner/ Reseller/ DistributorGlobal healthcare company and distribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• Oktal PharmacoreChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• Laboratorios RubiócoreChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• Artemis PharmacoreChannel Partner/ Reseller/ DistributorDistribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• MagnapharmcoreChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• FertillandcoreChannel Partner/ Reseller/ DistributorFertility-focused distribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• IMC QatarcoreChannel Partner/ Reseller/ DistributorDistribution partner for Lenus Pharma products in Qatar. Listed as a key partner on the Lenus Pharma partner page.
• Goodwill PharmacoreChannel Partner/ Reseller/ DistributorPharmaceutical distribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• Al-IttihadcoreChannel Partner/ Reseller/ DistributorDistribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• TaibacoreChannel Partner/ Reseller/ DistributorDistribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.
• Red Leaf MedicalcoreChannel Partner/ Reseller/ DistributorMedical distribution partner for Lenus Pharma products. Listed as a key partner on the Lenus Pharma partner page.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bausch + Lomb: Global ophthalmology company whose PreserVision AREDS2 product line directly competes with Lenus Pharma's PROMACULA areds2 variants. Comparable in targeting the AMD dietary-supplement category with clinically validated, AREDS2-compliant formulations.
• Theramex: Specialty pharma focused on women's health across contraception, fertility, and menopause. Directly comparable therapeutic categories to Lenus (fertility, menopause) with a similar branded specialty positioning.
• Exeltis: Global women's-health pharmaceutical company with fertility, contraception, and menopause products. Closely comparable to Lenus in therapeutic focus on reproductive and hormonal health and in deploying evidence-based, branded specialty products.
• Lo.Li. Pharma: Italian specialty pharmaceutical company focused on reproductive health, gynecology, and fertility supplements. Closely comparable to Lenus Pharma in therapeutic focus, evidence-based positioning, and channel-partner distribution model across multiple European markets.
• EyePromise: US-based eye-health supplement brand whose AREDS2-based formulations directly compete with Lenus's PROMACULA areds2 line. Closely comparable in evidence-based eye-health supplementation targeting ophthalmologists and optometrists.

Broad incumbents

• Bayer: Global consumer health and pharma incumbent whose Elevit prenatal/fertility supplement overlaps with Lenus's PROFERTIL franchise. Bayer's scale, consumer marketing budget, and broader women's-health portfolio make it a broader incumbent rather than a like-for-like niche peer.
• Angelini Pharma: Italian pharmaceutical group with a women's-health and OTC consumer-health portfolio overlapping with Lenus's fertility and menopause franchises. Larger and more diversified than Lenus, but active in the same therapeutic categories via similar evidence-led specialty brands.
• Merck KGaA: Diversified healthcare company with established fertility treatments (e.g., Gonal-f) that compete with PROFERTIL in the reproductive-health category, and a broader pharma portfolio. Overlap with Lenus in fertility is meaningful but is part of a much wider product range.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lenus-pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lenus Pharma